Search

everythinglearnresearchcommunity

for

Search:↓

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Scoring systems help doctors assess and treat skin diseases effectively.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Higher IL-17A levels indicate more severe alopecia areata.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

Lower testosterone levels in men may be linked to a higher risk of severe coronary artery disease.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

More severe alopecia areata can lower quality of life.

Collider bias can distort our understanding of COVID-19 risk and severity.

Severe COVID-19 often leads to hair loss in India.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

Higher apelin-12 levels may indicate more severe acne.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

No significant link between male pattern baldness and COVID-19 severity was found.

Dermatological diseases affect women's work performance more than men's.

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

PRO-C22 can help diagnose and monitor the severity of hidradenitis suppurativa.

Achieving 80% or more scalp hair regrowth is considered a successful treatment for significant hair loss.

Male-pattern baldness is weakly linked to some heart disease risk factors but not a strong indicator for heart disease.

More severe hair loss links to thicker heart fat, suggesting possible heart disease risk.

Male baldness is not significantly associated with coronary artery disease.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

New tools help doctors better assess and treat alopecia areata in kids by considering more than just hair loss.

Researchers created a fast, accurate computer program to measure hair loss in alopecia areata patients.